Minneapolis, MNNCT07624617Now EnrollingIRB Ready

Metastatic Breast Cancer Clinical Trial in Minneapolis, MN

Access cutting-edge metastatic breast cancer treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by University of Minnesota

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access metastatic breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related metastatic breast cancer treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this metastatic breast cancer clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Metastatic Breast Cancer Study in Minneapolis

We hypothesize that promoting a fasting state will strengthen the anti-cancer effects of PI3K inhibitors in metastatic breast cancer (MBC) treatment. The primary objective of this study is to assess acceptability of prolonged fasting in this population.

Sponsor: University of Minnesota

Who Can Participate

Inclusion Criteria

Age ≥18 years
Histologically confirmed metastatic breast cancer
Menopausal or medically ovarian suppressed
Currently receiving capivasertib therapy (2 tablets twice daily, 4 days per week)
Stable on current capivasertib regimen for at least 2 weeks
an ECOG performance status of 0-1
BMI ≥25kg/m2
Able to provide informed consent
Willing to comply with study procedures including CGM wear, food tracking by mCC app and dietary modifications
Access to smartphone or tablet for mobile application use

Exclusion Criteria

Type 1 diabetes mellitus
Uncontrolled type 2 diabetes (HbA1c \>9.0%)
History of severe hypoglycemia
Eating disorders or contraindications to fasting
Pregnancy or breastfeeding
Significant gastrointestinal disorders affecting food absorption
Unable to fast for medical reasons
Concurrent participation in other dietary intervention studies
A history of significantly abnormal lab results within 4 weeks of consent date, such as hematologic (Hgb \< 10.0, platelets \< 100), hepatic (LFTs \> 2X nl), renal (Cr \> 1.5)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT07624617) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Metastatic Breast Cancer Treatment Options in Minneapolis, MN

If you're searching for metastatic breast cancer treatment options in Minneapolis, MN, this clinical trial (NCT07624617) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all metastatic breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Minneapolis, MN

See all breast cancer clinical trials recruiting in Minneapolis — not just this study.

Browse Breast Cancer Trials in Minneapolis →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN